These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2156209)

  • 1. The p53 nuclear localisation signal is structurally linked to a p34cdc2 kinase motif.
    Addison C; Jenkins JR; Stürzbecher HW
    Oncogene; 1990 Mar; 5(3):423-6. PubMed ID: 2156209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis.
    Stürzbecher HW; Maimets T; Chumakov P; Brain R; Addison C; Simanis V; Rudge K; Philp R; Grimaldi M; Court W
    Oncogene; 1990 Jun; 5(6):795-81. PubMed ID: 2141683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of protein kinase activities associated with p53-large-T immune complexes from SV40-transformed rat cells.
    Müller E; Boldyreff B; Scheidtmann KH
    Oncogene; 1993 Aug; 8(8):2193-205. PubMed ID: 8393163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 is associated with p34cdc2 in transformed cells.
    Milner J; Cook A; Mason J
    EMBO J; 1990 Sep; 9(9):2885-9. PubMed ID: 2167834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse p53 blocks SV40 DNA replication in vitro and downregulates T antigen DNA helicase activity.
    Stürzbecher HW; Brain R; Maimets T; Addison C; Rudge K; Jenkins JR
    Oncogene; 1988 Oct; 3(4):405-13. PubMed ID: 2856250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization.
    Stürzbecher HW; Brain R; Addison C; Rudge K; Remm M; Grimaldi M; Keenan E; Jenkins JR
    Oncogene; 1992 Aug; 7(8):1513-23. PubMed ID: 1321401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of a protein kinase which is activated by SV40 large T-antigen and phosphorylates the tumor suppressor protein p53.
    Müller E; Scheidtmann KH
    Oncogene; 1995 Mar; 10(6):1175-85. PubMed ID: 7700642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
    McKendrick L; Meek DW
    Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SV40 large T-antigen: dual oncogene.
    Butel JS
    Cancer Surv; 1986; 5(2):343-65. PubMed ID: 3022925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of large tumour antigen by cdc2 stimulates SV40 DNA replication.
    McVey D; Brizuela L; Mohr I; Marshak DR; Gluzman Y; Beach D
    Nature; 1989 Oct; 341(6242):503-7. PubMed ID: 2552322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of SV40 large T antigen and p53 on nuclear transport capacity in BALB/c 3T3 cells.
    Feldherr C; Cole C; Lanford RE; Akin D
    Exp Cell Res; 1994 Jul; 213(1):164-71. PubMed ID: 8020587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural aspects of the p53 protein in relation to gene evolution.
    Soussi T; Caron de Fromentel C; May P
    Oncogene; 1990 Jul; 5(7):945-52. PubMed ID: 2142762
    [No Abstract]   [Full Text] [Related]  

  • 13. An extended bipartite nuclear localization signal in Smad4 is required for its nuclear import and transcriptional activity.
    Xiao Z; Latek R; Lodish HF
    Oncogene; 2003 Feb; 22(7):1057-69. PubMed ID: 12592392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex of simian virus large T antigen and p53 can bind DNA specifically.
    Long SB; Ho HY; Chen CL; Lai MD
    Anticancer Res; 1995; 15(4):1375-80. PubMed ID: 7654024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine mapping and regulation of the association of p53 with p34cdc2.
    Wagner P; Fuchs A; Götz C; Nastainczyk W; Montenarh M
    Oncogene; 1998 Jan; 16(1):105-11. PubMed ID: 9467949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase activity associated with immunopurified p53 protein.
    Kraiss S; Barnekow A; Montenarh M
    Oncogene; 1990 Jun; 5(6):845-55. PubMed ID: 2141685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression.
    Fiscella M; Ullrich SJ; Zambrano N; Shields MT; Lin D; Lees-Miller SP; Anderson CW; Mercer WE; Appella E
    Oncogene; 1993 Jun; 8(6):1519-28. PubMed ID: 8502477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of a highly conserved domain on p53 as a result of gene deletion during Friend virus-induced erythroleukemia.
    Munroe DG; Rovinski B; Bernstein A; Benchimol S
    Oncogene; 1988 Jun; 2(6):621-4. PubMed ID: 3290808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational modification of p53.
    Meek DW
    Semin Cancer Biol; 1994 Jun; 5(3):203-10. PubMed ID: 7948948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rate of nuclear cytoplasmic protein transport is determined by the casein kinase II site flanking the nuclear localization sequence of the SV40 T-antigen.
    Rihs HP; Jans DA; Fan H; Peters R
    EMBO J; 1991 Mar; 10(3):633-9. PubMed ID: 1848177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.